Rezolute, Inc. Insider Trading
RZLT
Insiders bought 236K on the open market and sold nothing.
Get an email when RZLT's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30 | Daron Evans CFO | Bought | 10,000 | $2.85 | 29K | 2.0% | Form 4 |
| Dec 16, 2025 | Wladimir Hogenhuis Director | Bought | 5,650 | $1.69 | 10K | 5.0% | Form 4 |
| Dec 16, 2025 | Brian Kenneth Roberts Chief Medical Officer | Bought | 28,000 | $1.70 | 48K | 9.5% | Form 4 |
| Dec 15, 2025 | Daron Evans CFO | Bought 3 parts | 45,000 | $1.77 average | 80K | 9.6% | Form 4 |
| Dec 15, 2025 | Nevan C Elam CEO | Bought | 32,000 | $1.59 | 51K | 5.3% | Form 4 |
| Dec 15, 2025 | Sunil Ratilal Karnawat Chief Commercial Officer | Bought 2 parts | 12,100 | $1.62 average | 20K | 17% | Form 4 |
| Jun 25, 2025 | Brian Kenneth Roberts Chief Medical Officer | Bought | 2,500 | $4.38 | 11K | 17% | Form 4 |
| Jun 24, 2025 | Daron Evans CFO | Bought | 5,000 | $4.05 | 20K | 1.4% | Form 4 |
| Jun 13, 2025 | Young-Jin Kim Director | Bought | 1,230,769 | $3.25 | $4M | 17% | Form 4 |
| Jun 13, 2025 | Nerissa Kreher Director | Bought | 3,076 | $3.25 | 10K | 8.9% | Form 4 |
| Mar 31, 2025 | Wladimir Hogenhuis Director | Bought | 6,758 | $2.92 | 20K | 8.7% | Form 4 |
| Mar 27, 2025 | Nevan C Elam CEO | Bought | 12,302 | $2.85 | 35K | 5.8% | Form 4 |
| Mar 26, 2025 | Daron Evans CFO | Bought 2 parts | 20,000 | $2.89 average | 58K | 6.5% | Form 4 |
| Feb 18, 2025 | Wladimir Hogenhuis Director | Bought | 10,000 | $4.70 | 47K | 15% | Form 4 |
| Dec 18, 2024 | Daron Evans CFO | Bought | 10,000 | $4.29 | 43K | 4.5% | Form 4 |
| Dec 12, 2024 | Daron Evans CFO | Bought | 9,000 | $4.60 | 41K | 4.2% | Form 4 |
| Dec 10, 2024 | Daron Evans CFO | Bought | 10,549 | $5.04 | 53K | 5.2% | Form 4 |
- Mar 30Daron EvansCFO · bought 10,000 at $2.8529K2.0% of stake
- Dec 16, 2025Wladimir HogenhuisDirector · bought 5,650 at $1.6910K5.0% of stake
- Dec 16, 2025Brian Kenneth RobertsChief Medical Officer · bought 28,000 at $1.7048K9.5% of stake
- Dec 15, 2025Daron EvansCFO · bought 45,000 at avg $1.7780K9.6% of stake
- Dec 15, 2025Nevan C ElamCEO · bought 32,000 at $1.5951K5.3% of stake
- Dec 15, 2025Sunil Ratilal KarnawatChief Commercial Officer · bought 12,100 at avg $1.6220K17% of stake
- Jun 25, 2025Brian Kenneth RobertsChief Medical Officer · bought 2,500 at $4.3811K17% of stake
- Jun 24, 2025Daron EvansCFO · bought 5,000 at $4.0520K1.4% of stake
- Jun 13, 2025Young-Jin KimDirector · bought 1,230,769 at $3.25$4M17% of stake
- Jun 13, 2025Nerissa KreherDirector · bought 3,076 at $3.2510K8.9% of stake
- Mar 31, 2025Wladimir HogenhuisDirector · bought 6,758 at $2.9220K8.7% of stake
- Mar 27, 2025Nevan C ElamCEO · bought 12,302 at $2.8535K5.8% of stake
- Mar 26, 2025Daron EvansCFO · bought 20,000 at avg $2.8958K6.5% of stake
- Feb 18, 2025Wladimir HogenhuisDirector · bought 10,000 at $4.7047K15% of stake
- Dec 18, 2024Daron EvansCFO · bought 10,000 at $4.2943K4.5% of stake
- Dec 12, 2024Daron EvansCFO · bought 9,000 at $4.6041K4.2% of stake
- Dec 10, 2024Daron EvansCFO · bought 10,549 at $5.0453K5.2% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with RZLT
Held by ETFs
RZLT is in 13 US ETFs. The largest of them, with RZLT's weight in each:
Spot a number that looks wrong? Check it in RZLT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing RZLT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.